Assoc. Prof. Priv. Doz. Julia Furtner-Srajer, MD, PhD, MBA
Department of Biomedical Imaging and Image-guided Therapy (Division of Neuroradiology and Musculoskeletal Radiology)
Position: Associate Professor
ORCID: 0000-0001-8258-3681
julia.furtner@meduniwien.ac.at
Keywords
Brain tumor biomarkers; Functional Neuroimaging; Magnetic Resonance Imaging; Neuroimaging; Neurooncology; Positron-Emission Tomography; Sarcopenia
Techniques, methods & infrastructure
- Structural and advanced Neuroimaging,
- PET/MRI,
- intra-operative MRI,
- Radiomics/Radiogenomics
Selected publications
- Steindl, A. et al., 2020. Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength Evaluation. Journal of Clinical Medicine, 9(5), p.1272. Available at: http://dx.doi.org/10.3390/jcm9051272.
- Furtner, J. et al., 2019. Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial. Neuro-Oncology, 21(12), pp.1587–1594. Available at: http://dx.doi.org/10.1093/neuonc/noz131.
- Furtner, J. et al., 2019. Noninvasive Differentiation of Meningiomas and Dural Metastases Using Intratumoral Vascularity Obtained by Arterial Spin Labeling. Clinical Neuroradiology, 30(3), pp.599–605. Available at: http://dx.doi.org/10.1007/s00062-019-00808-x.
- Klughammer, J. et al., 2018. The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space. Nature Medicine, 24(10), pp.1611–1624. Available at: http://dx.doi.org/10.1038/s41591-018-0156-x.
- Furtner, J. et al., 2015. Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma. Neuro-Oncology, 18(3), pp.401–407. Available at: http://dx.doi.org/10.1093/neuonc/nov183.